Yu-Chun Huang Selected Research

2-phenyl-4-oxohydroquinoline

2/2008	CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo.
6/2007	Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Chun Huang Research Topics

Disease

7	Neoplasms (Cancer) 09/2020 - 05/2004
3	Melanoma (Melanoma, Malignant) 10/2013 - 11/2011
2	Anastomotic Leak 11/2018 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 02/2008 - 06/2007
2	Prostatic Neoplasms (Prostate Cancer) 06/2007 - 11/2006
2	Leukemia 01/2005 - 05/2004
1	Dysbiosis 12/2021
1	Infections 01/2021
1	Classical Swine Fever (Swine Fever) 01/2021
1	Acne Vulgaris 04/2019
1	Rectal Neoplasms (Rectal Cancer) 11/2016
1	Hyperlipidemias (Hyperlipidemia) 10/2013
1	Hyperglycemia 10/2013
1	Eosinophilia 11/2012
1	Hyperplasia 11/2012
1	Inflammation (Inflammations) 11/2012
1	Breast Neoplasms (Breast Cancer) 06/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2007
1	Colonic Neoplasms (Colon Cancer) 08/2006
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2005
1	Acute Promyelocytic Leukemia 01/2005
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2005
1	Carcinogenesis 06/2003
1	Lung Neoplasms (Lung Cancer) 12/2002

Drug/Important Bio-Agent (IBA)

3	Melanins (Melanin)IBA 10/2013 - 11/2011
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2020 - 06/2007
2	Monophenol Monooxygenase (Tyrosinase)IBA 10/2013 - 11/2011
2	2-phenyl-4-oxohydroquinolineIBA 02/2008 - 06/2007
2	TubulinIBA 06/2007 - 01/2005
2	Proteins (Proteins, Gene)FDA Link 08/2006 - 01/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	AntibodiesIBA 01/2021
1	EpitopesIBA 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 04/2019
1	Capecitabine (Xeloda)FDA Link 11/2016
1	Fenofibrate (CiL)FDA LinkGeneric 10/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2013
1	p38 Mitogen-Activated Protein KinasesIBA 10/2013
1	AllergensIBA 11/2012
1	Messenger RNA (mRNA)IBA 11/2012
1	AntioxidantsIBA 11/2012
1	EnzymesIBA 11/2012
1	ankaflavinIBA 11/2012
1	FlavonoidsIBA 03/2012
1	hesperetinIBA 03/2012
1	AcidsIBA 03/2012
1	flavanoneIBA 11/2011
1	Microphthalmia-Associated Transcription FactorIBA 11/2011
1	naringeninIBA 11/2011
1	CateninsIBA 11/2011
1	2'- fluoro- 6,7- methylenedioxy- 2- phenyl- 4- quinoloneIBA 02/2008
1	CaspasesIBA 02/2008
1	Antimitotic AgentsIBA 02/2008
1	QuinolonesIBA 02/2008
1	Antineoplastic Agents (Antineoplastics)IBA 02/2008
1	Hormones (Hormone)IBA 06/2007
1	Cyclin-Dependent Kinase Inhibitor p27IBA 11/2006
1	Calcitriol (Calcijex)FDA LinkGeneric 11/2006
1	VitaminsIBA 08/2006
1	clavulonesIBA 01/2005
1	PhosphatidylserinesIBA 01/2005
1	ProstaglandinsIBA 01/2005
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2005
1	denbinobinIBA 01/2005
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2005
1	clavulone IIIBA 01/2005
1	cyclopentenoneIBA 01/2005
1	AlkaloidsIBA 05/2004
1	evodiamineIBA 05/2004
1	CarcinogensIBA 06/2003
1	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 06/2003
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2002

Therapy/Procedure

2	Therapeutics 05/2015 - 10/2013
1	Laparotomy 11/2018
1	Length of Stay 01/2017
1	Analgesia 01/2017
1	Drug Therapy (Chemotherapy) 11/2016
1	Chemoradiotherapy 11/2016